Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Feb;12(1):564-572.
doi: 10.1002/ehf2.15078. Epub 2024 Oct 17.

Association between clinician team segregation, receipt of cardiovascular care and outcomes in valvular heart diseases

Affiliations
Multicenter Study

Association between clinician team segregation, receipt of cardiovascular care and outcomes in valvular heart diseases

Ikeoluwapo Kendra Bolakale-Rufai et al. ESC Heart Fail. 2025 Feb.

Abstract

Aims: Racial disparities exist in clinical outcomes for valvular heart disease (VHD). It is unknown whether clinician segregation contributes to these disparities. Among an adequately insured population, we evaluated the relationship between clinician segregation in a hospital and receipt of care by a cardiologist according to patient race. We also evaluated the association between clinician segregation, race and care by a cardiologist on 30-day readmission and 1-year survival.

Methods and results: Using Optum's Clinformatics® Data Mart Database (CDM, US commercial and Medicare beneficiaries) from 2010 to 2018, we identified patients with a primary diagnosis of VHD. Hospitals were categorized into low, medium and high segregation groups (SG), according to clinician segregation index (SI). SI can range from 0-1 (0: the ratio of Black to White patients is the same for all clinicians; 1: each clinician treats only Black or only White patients). Outcomes were analysed using generalized linear mixed effect models. Among 8649 patients [median age 75 (67-82), 45.4% female, 16.1% Black, 83.9% White], odds of care from a cardiologist did not vary across race for all SGs [Low SG adjusted odds ratio (aOR): 0.79 (95% CI: 0.58-1.08), P = 0.14; Medium SG aOR: 0.86 (95% CI: 0.60-1.25), P = 0.43; High SG aOR: 1.07 (95% CI: 0.68-1.69), P = 0.76]. Among those that received care from a cardiologist, there was no difference in the 30-day readmission between Black and White patients across SGs [Low SG aOR: 1.05 (95% CI: 0.83-1.31), P = 0.70; Medium SG aOR: 1.22 (95% CI: 0.92-1.61), P = 0.17; High SG aOR: 0.81 (95% CI: 0.57-1.17), P = 0.27]. Among patients that did not receive care from a cardiologist, Black patients in low SG had higher odds of 30-day readmission compared to White patients [aOR: 2.74 (95%CI:1.38-5.43), P < 0.01]. Odds of 1-year survival were similar across race for all SG irrespective of receipt of care from a cardiologist [seen by a cardiologist: Low SG aOR: 1.13 (95% CI: 0.86-1.48), P = 0.38; Medium SG aOR: 0.83 (95% CI: 0.59-1.17), P = 0.29; High SG aOR: 1.01 (95% CI: 0.66-1.52), P = 0.98; not seen by a cardiologist: Low SG aOR: 0.56 (95% CI: 0.23-1.34), P = 0.19; Medium SG aOR: 0.81 (95% CI: 0.28-2.37), P = 0.70; High SG aOR: 0.63 (95% CI: 0.23-1.74), P = 0.37].

Conclusions: Among an insured population, race was not associated with care by a cardiologist for VHD or survival. Black patients not seen by cardiologists had higher odds of 30-day readmission in low clinician SG.

Keywords: cardiovascular diseases; health equity; quality of care; racial disparities; segregation index; structural racism.

PubMed Disclaimer

Conflict of interest statement

The authors of this article disclose no financial or personal relationships with a third party whose interests could be positively or negatively influenced by the article's content.

Ikeoluwapo Kendra Bolakale‐Rufai, MD, MS; Shannon M. Knapp, PhD; Janina Quintero Bisono, MD; Adedoyin Johnson, MD, PhD; Wanda Moore CCHE; Ekow Yankah Esq; Ryan Yee, MS; Dalancee Trabue MS; Brahmajee Nallamothu, MD, MPH; John M. Hollingsworth, MD, MS; Stephen Watty, MD; Francesca Williamson, PhD; Natalie Pool, PhD; Megan Hebdon, PhD; Nneamaka Ezema, PM, CCRA, MBA; Quinn Capers, MD, FACC; Courtland Blount, MD; Nia Kimbrough; Johnnie Washington, MSW; Denee Johnson; Jalynn Evans; Brandi Foree, NP; Chaplain Rev Anastacia Holman; Karen Lightbourne; David Brown, MD; Brownsyne Tucker Edmonds, MD, MPH, MS; Khadijah Breathett, MD, MS all declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Adjusted odds ratio of receiving care from a cardiologist according to hospital segregation groups. The logistic regression model included effect of race, SG, interaction of race (Black and White) and SG (low, medium and high), gender, Charlson co‐morbidity index (with age), hospital region (Midwest, Northeast and South) and a random hospital intercept.
Figure 2
Figure 2
Adjusted odds ratio of 30‐day readmission in VHD according to the receipt of care from a cardiologist and hospital SG. There are separate panels for those not seen by cardiologists and those seen by a cardiologist. The logistic regression model included the effect of receipt of care by a cardiologist, two‐ and three‐way interactions of care by cardiologist, SG and race.
Figure 3
Figure 3
Adjusted odds ratio of 1‐year survival in VHD according to the receipt of care from a cardiologist and hospital SG. There are separate panels for those not seen by cardiologists and those seen by a cardiologist. The logistic regression model included the effect of receipt of care by a cardiologist, two‐ and three‐way interactions of care by cardiologist, SG and race.

Similar articles

References

    1. Taghizadeh B, Ghavami L, Derakhshankhah H, Zangene E, Razmi M, Jaymand M, et al. Biomaterials in valvular heart diseases. Front Bioeng Biotechnol 2020;8:529244. doi:10.3389/fbioe.2020.529244 - DOI - PMC - PubMed
    1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006‐3008. doi:10.1161/01.cir.0000047200.36165.b8 - DOI - PubMed
    1. Paniagua D, Condado JA, Besso J, Vélez M, Burger B, Bibbo S, et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J 2005;32:393‐398. - PMC - PubMed
    1. Bourantas CV, Serruys PW. Evolution of transcatheter aortic valve replacement. Circ Res 2014;114:1037‐1051. doi:10.1161/CIRCRESAHA.114.302292 - DOI - PubMed
    1. Lamprea‐Montealegre JA, Oyetunji S, Bagur R, Otto CM. Valvular heart disease in relation to race and ethnicity. J Am Coll Cardiol 2021;78:2493‐2504. doi:10.1016/j.jacc.2021.04.109 - DOI - PubMed

Publication types

LinkOut - more resources